Table 3.
Factors influencing the use of IA-HA and brand selection.
| NUMBER OF RESPONSES* N (%) N=117 |
|
|---|---|
| Factors influencing the use of IA-HA | |
| Personal experience and clinical results | 84 (71.8%) |
| Patient not suitable/unwilling to undergo operative intervention | 61 (52.1%) |
| Sufficient evidence that supports decision to use IA-HA | 51 (43.6%) |
| Failed previous treatments | 49 (41.9%) |
| Age of patient | 38 (32.5%) |
| Guideline recommendations provided by organizations | 32 (27.4%) |
| A viable mechanism of action presented in the literature | 31 (26.5%) |
| Overall cost of treatment | 30 (25.6%) |
| Inclusion of ha treatments in the formulary | 12 (10.3%) |
| No response/do not use IA-HA | 15 (12.8%) |
| Factors influencing ia-ha brand selection | |
| Personal experience and clinical outcomes | 57 (48.7%) |
| Sufficient evidence that supports your chosen brand | 47 (40.2%) |
| Overall cost of treatment | 47 (40.2%) |
| Injection regimen of your preferred brand | 46 (40.2%) |
| Molecular weight of the hyaluronic acid product | 38 (32.5%) |
| Product method used to create product (Bio-HA vs AD-HA) | 25 (21.4%) |
| Reputation of company | 25 (21.4%) |
| Cross-linking of product | 23 (19.7%) |
| Guideline recommendations provided by organizations | 14 (12.0%) |
| The information for brands in the formulary | 7 (6.0%) |
| No response/do not use IA-HA | 24 (20.5%) |
Note:
*
Multiple response options were permitted.